Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex
Go back to Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex| PARTNERRE LTD. (NASDAQ: PRE) | Delayed: 24.47 -1.15 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.62 | 52 Week High | $141.25 | |||
| Open | $25.50 | 52 Week Low | $111.52 | |||
| Day High | $25.96 | P/E | 2.31 | |||
| Day Low | $24.40 | EPS | $10.58 | |||
| Volume | 77,166 | |||||
| PARTNERRE LTD. (NASDAQ: PRE) | Delayed: 24.47 -1.15 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.62 | 52 Week High | $141.25 | |||
| Open | $25.50 | 52 Week Low | $111.52 | |||
| Day High | $25.96 | P/E | 2.31 | |||
| Day Low | $24.40 | EPS | $10.58 | |||
| Volume | 77,166 | |||||
| PARTNERRE LTD. (NASDAQ: PRE) | Delayed: 24.47 -1.15 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.62 | 52 Week High | $141.25 | |||
| Open | $25.50 | 52 Week Low | $111.52 | |||
| Day High | $25.96 | P/E | 2.31 | |||
| Day Low | $24.40 | EPS | $10.58 | |||
| Volume | 77,166 | |||||

